The relationship of insulin resistance measured by reliable indexes to coronary artery disease risk factors and outcomes - A systematic review

Canadian Journal of Cardiology

Volumn 17, Issue 7, 2001, Pages 797-805

  Smiley, T ^a   Oh, P ^a   Shane, L G ^a  

^a Pharmavision Health Consulting Inc   (Canada)

Author keywords

Coronary disease; Diabetes mellitus; Health outcomes; Insulin

Indexed keywords

C PEPTIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DATA BASE; DISEASE ASSOCIATION; DISEASE MARKER; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOMES RESEARCH; POPULATION RESEARCH; POPULATION RISK; PROTEIN BLOOD LEVEL; PUBLICATION; RELIABILITY; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; RISK FACTORS;

EID: 0034888781     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Mortality from coronary heart disease in subjects with Type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
2. Cardiovascular risk continuum: Implications of insulin resistance and diabetes
3. Type 2 diabetes care: The role of insulin-sensitizing agents and practical implications for cardiovascular disease prevention
4. How to measure insulin sensitivity
5. Insulin sensitivity in subjects with type 2 diabetes: Relationship to cardiovascular risk factors: The Insulin Resistance Atherosclerosis Study
6. Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: Comparison with the "Minimal Model"
7. Role of insulin resistance in human disease
8. Evidence of higher insulin resistance in NIDDM patients with ischemic heart disease
9. Low insulin sensitivity is associated with clustering of cardiovascular risk factors
10. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease
11. Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests: The Insulin Resistance Atherosclerosis Study
12. Insulin and risk of cardiovascular disease: A meta-analysis
13. Hyperinsulinemia as an independent risk factor for ischemic heart disease
14. Plasma insulin as coronary heart disease risk factor: Relationship to other risk factors and predictive value over 9.5 year follow-up of the Helsinki Policemen Study population
15. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population
16. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome
17. Hyperinsulinemia is not a major coronary risk factor in elderly men: The study of men born in 1913
18. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: The Paris prospective study, a 15-year follow-up
19. Insulin as a predictor of coronary heart disease: Interaction with apolipoprotein E phenotype: A report from the Multiple Risk Factor Intervention Trial
20. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations
21. Cardiovascular risk factors and hyperinsulinemia in elderly men: The Honolulu Heart Program
22. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in patients with coronary artery disease independent of obesity
23. Hyperinsulinemia and clustering of cardiovascular risk factors in middle-aged hypertensive Finnish men and women
24. Serum insulin and incident coronary heart disease in middle-aged British men
25. High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of Type 2 diabetes
26. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men
27. Homeostasis model assessment as a clinical index of insulin resistance in Type 2 diabetic patients treated with sulfonylureas
28. A prospective analysis of the HOMA model: The Mexico City Diabetes Study
29. Insulin sensitivity and atherosclerosis
30. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
31. How to measure insulin action in vivo
32. Homeostasis Model Assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity
33. Peripheral, rather than hepatic, insulin resistance and atherogenic lipoprotein phenotype predict cardiovascular complications in NIDDM
34. Relationship between insulin resistance and risk factors for cardiovascular disease in Japanese non-insulin-dependent diabetic patients
35. Prevalence of macro- and microvascular diseases in non-insulin-dependent diabetic and borderline glucose-intolerant subjects with insulin resistance syndrome
36. Insulin resistance in patients with a recent diagnosis of coronary artery disease
37. Insulin resistance and coronary artery disease
38. Metabolic features of patients with and without coronary heart disease but with a superimposable cluster of cardiovascular risk factors
39. Patterns of glucose and lipid abnormalities in Black NIDDM subjects
40. Coronary heart disease risk factors profiles in black patients with non-insulin dependent diabetes mellitus: Paradoxic patterns
41. Are body mass or insulin resistance independently associated with cardiovascular risk factors in non-diabetic elderly Nigerians?
42. Carotid artery wall intima-media thickness is associated with insulin-medicated glucose disposal in men at high and low coronary risk
43. Determinants of insulin sensitivity and consequences for lipoproteins and blood pressure in subjects with non-insulin-dependent diabetes mellitus
44. Femoral atherosclerosis in middle-aged subjects: Associations with cardiovascular risk factors and insulin resistance
45. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of Type 2 diabetes mellitus
46. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors
47. Asymptomatic atherosclerosis and insulin resistance
48. Insulin sensitivity, lipids, and blood pressure in young American Blacks
49. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients
50. Resistance to insulin-stimulated-glucose uptake in patients with hypertension
51. Insulin resistance and cardiovascular complications in patients with essential hypertension
52. Insulin resistance in essential hypertension is related to plasma renin activity
53. Insulin resistance in essential hypertension
54. Prevalence of insulin resistance in metabolic disorders: The Bruneck Study
55. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden
56. U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population
57. Prospective analysis of the insulin-resistance syndrome (Syndrome X)
58. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: The Rancho Bernardo Study, 1984-1991
59. Predictors of coronary heart disease and death in NIDDM: The Diabetes Intervention Study experience
60. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12 year follow-up and development of coronary heart disease in Edinburgh men
61. Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians
62. Hyperinsulinemic microalbuminuria: A new risk indicator for coronary heart disease
63. Clustering of cardiovascular risk factors in urban Asian Indians
64. The relationship between glucose and incident cardiovascular events: A meta-regression analysis of published data from 20 studies of 95,873 individuals followed for 12.4 years
65. Dysglycemia and risk of cardiovascular disease
66. Hyperglycemia and cardiovascular disease in Type 2 diabetes
67. Pathophysiology of insulin resistance in human disease
68. Reducing the burden of diabetes: Managing cardiovascular disease
69. Insulin resistance implications for Type II diabetes mellitus and coronary heart disease